Literature DB >> 7066170

Serum protein binding and free concentration of phenytoin and phenobarbitone in pregnancy.

S S Chen, E Perucca, J N Lee, A Richens.   

Abstract

1 The effect of pregnancy on the binding of phenytoin and phenobarbitone to serum proteins was studied in normal women and in drug treated epileptic women. 2 The binding of both drugs was reduced during pregnancy. The reduction correlated positively with the gestational age and negatively with the serum albumin concentration. 3 In spite of the increase in unbound fraction, both the total and free serum concentrations of phenytoin were decreased in late pregnancy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7066170      PMCID: PMC1402062          DOI: 10.1111/j.1365-2125.1982.tb01420.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution.

Authors:  P K Lunde; A Rane; S J Yaffe; L Lund; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1970 Nov-Dec       Impact factor: 6.875

2.  Rapid determination of diphenylhydantoin in blood plasma by gas-liquid chromatography.

Authors:  J MacGee
Journal:  Anal Chem       Date:  1970-03       Impact factor: 6.986

3.  Albumin standards and the measurement of serum albumin with bromcresol green.

Authors:  B T Doumas; W A Watson; H G Biggs
Journal:  Clin Chim Acta       Date:  1971-01       Impact factor: 3.786

4.  Plasma drug level monitoring in pregnancy.

Authors:  M J Eadie; C M Lander; J H Tyrer
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

5.  Phenytoin and phenobarbitone plasma clearance during pregnancy.

Authors:  K I Mygind; M Dam; J Christiansen
Journal:  Acta Neurol Scand       Date:  1976-08       Impact factor: 3.209

6.  Antiepileptic drugs: metabolism in pregnancy.

Authors:  M Dam; J Christiansen; O Munck; K I Mygind
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

7.  Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients.

Authors:  A H Knight; E G Rhind
Journal:  Epilepsia       Date:  1975-03       Impact factor: 5.864

8.  Plasma protein binding interaction between phenytoin and valproic acid in vitro.

Authors:  A Monks; S Boobis; J Wadsworth; A Richens
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

9.  Metabolism of diphenylhydantoin (phenytoin) during pregnancy.

Authors:  M J Landon; M Kirkley
Journal:  Br J Obstet Gynaecol       Date:  1979-02

10.  Plasma anticonvulsant concentrations during pregnancy.

Authors:  C M Lander; V E Edwards; M J Eadie; J H Tyrer
Journal:  Neurology       Date:  1977-02       Impact factor: 9.910

View more
  16 in total

1.  Applying organ clearance concepts in a clinical setting.

Authors:  Jorge Duconge
Journal:  Am J Pharm Educ       Date:  2008-10-15       Impact factor: 2.047

Review 2.  Therapeutic drug monitoring in pregnancy: rationale and current status.

Authors:  C Knott; F Reynolds
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 3.  Plasma protein binding of drugs in pregnancy and in neonates.

Authors:  L J Notarianni
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

4.  Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women.

Authors:  A Philipson; G Stiernstedt; M Ehrnebo
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

Review 5.  The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state.

Authors:  M D Hill; F P Abramson
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

Review 6.  Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.

Authors:  Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

7.  A survey of pharmacokinetic data from pregnant women.

Authors:  A J Cummings
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

Review 8.  Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations.

Authors:  James W McAuley; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

9.  Longitudinal effects of pregnancy on the pharmacokinetics of theophylline.

Authors:  M J Gardner; M Schatz; L Cousins; R Zeiger; E Middleton; W J Jusko
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 10.  Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?

Authors:  Page B Pennell
Journal:  Epilepsia       Date:  2008-12       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.